$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2024 Q1 Form 10-Q Financial Statement

#000118518524000485 Filed on May 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $1.398M $1.313M
YoY Change 6.49% -8.04%
Cost Of Revenue $258.4K $295.2K
YoY Change -12.48% 24.24%
Gross Profit $1.139M $1.017M
YoY Change 12.0% -14.49%
Gross Profit Margin 81.51% 77.51%
Selling, General & Admin $954.8K $925.6K
YoY Change 3.16% 0.23%
% of Gross Profit 83.8% 90.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.427K $9.379K
YoY Change 0.51% 123.31%
% of Gross Profit 0.83% 0.92%
Operating Expenses $1.223M $1.230M
YoY Change -0.61% 32.61%
Operating Profit $175.2K $82.46K
YoY Change 112.47% -68.54%
Interest Expense $99.25K $99.82K
YoY Change -0.57%
% of Operating Profit 56.65% 121.06%
Other Income/Expense, Net $10.73K $34.00K
YoY Change -68.44% 233.71%
Pretax Income $274.4K $182.3K
YoY Change 50.57% -30.46%
Income Tax $77.04K $51.16K
% Of Pretax Income 28.07% 28.07%
Net Earnings $197.4K $131.1K
YoY Change 50.56% -30.46%
Net Earnings / Revenue 14.12% 9.99%
Basic Earnings Per Share $0.02 $0.01
Diluted Earnings Per Share $0.02 $0.01
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.82M $10.84M
YoY Change -0.25% 2.89%
Cash & Equivalents $2.839M $1.995M
Short-Term Investments $7.977M $8.848M
Other Short-Term Assets $218.8K $170.2K
YoY Change 28.53% 60.07%
Inventory
Prepaid Expenses $179.9K $170.2K
Receivables $879.1K $997.7K
Other Receivables $0.00 $3.000K
Total Short-Term Assets $11.91M $12.01M
YoY Change -0.83% 4.42%
LONG-TERM ASSETS
Property, Plant & Equipment $71.72K $88.24K
YoY Change -18.72% -6.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $7.110K
YoY Change 0.0% -78.71%
Total Long-Term Assets $125.7K $136.5K
YoY Change -7.93% 6.79%
TOTAL ASSETS
Total Short-Term Assets $11.91M $12.01M
Total Long-Term Assets $125.7K $136.5K
Total Assets $12.04M $12.15M
YoY Change -0.91% 4.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $148.1K $227.3K
YoY Change -34.86% 267.6%
Accrued Expenses $336.2K $287.6K
YoY Change 16.91% -21.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.027M $676.0K
YoY Change 51.87% 10.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.97K $10.52K
YoY Change 13.78%
Total Long-Term Liabilities $11.97K $10.52K
YoY Change 13.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.027M $676.0K
Total Long-Term Liabilities $11.97K $10.52K
Total Liabilities $1.039M $702.2K
YoY Change 47.91% 13.15%
SHAREHOLDERS EQUITY
Retained Earnings $10.57M $11.02M
YoY Change -4.06%
Common Stock $12.80K $12.80K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.00M $11.45M
YoY Change
Total Liabilities & Shareholders Equity $12.04M $12.15M
YoY Change -0.91% 4.44%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $197.4K $131.1K
YoY Change 50.56% -30.46%
Depreciation, Depletion And Amortization $9.427K $9.379K
YoY Change 0.51% 123.31%
Cash From Operating Activities $290.9K -$41.38K
YoY Change -803.08% -109.01%
INVESTING ACTIVITIES
Capital Expenditures $3.749K $209.00
YoY Change 1693.78% -103.41%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.749K -$209.00
YoY Change 1693.78% -96.59%
FINANCING ACTIVITIES
Cash Dividend Paid $14.16K $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$14.16K $0.00
YoY Change
NET CHANGE
Cash From Operating Activities $290.9K -$41.38K
Cash From Investing Activities -$3.749K -$209.00
Cash From Financing Activities -$14.16K $0.00
Net Change In Cash $273.0K -$41.59K
YoY Change -756.5% -109.18%
FREE CASH FLOW
Cash From Operating Activities $290.9K -$41.38K
Capital Expenditures $3.749K $209.00
Free Cash Flow $287.2K -$41.59K
YoY Change -790.53% -108.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NONE
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei City Area Code
CityAreaCode
949
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
721-8272
CY2024Q1 dei Security12b Title
Security12bTitle
None
CY2024Q1 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2839036 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2565992 usd
CY2024Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7976997 usd
CY2023Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7877752 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32850 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32814 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
879119 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1020580 usd
CY2024Q1 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
38871 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
38871 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179879 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179702 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
11913902 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11682897 usd
CY2024Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
259532 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
255783 usd
CY2024Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
281152 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277403 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
209436 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200009 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71716 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77394 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46890 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2024Q1 us-gaap Assets
Assets
12039618 usd
CY2023Q4 us-gaap Assets
Assets
11823890 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
148069 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159789 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
336185 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
367609 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
373487 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
296452 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
94858 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
109013 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34920 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44519 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
39107 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
30919 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1026626 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1008301 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1038596 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1020271 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10572149 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10374746 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11001022 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12039618 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11823890 usd
CY2024Q1 us-gaap Revenues
Revenues
1397831 usd
CY2023Q1 us-gaap Revenues
Revenues
1312643 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9427 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9379 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
36 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
230 usd
CY2024Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
61399 usd
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56254 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
672054 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
662224 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
85493 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
73102 usd
CY2024Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
79456 usd
CY2023Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
83481 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
168205 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
177759 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
10732 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
34002 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
135836 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
133756 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1222638 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1230187 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
175193 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
82456 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
99245 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
99816 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
99245 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
99816 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
274438 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
182272 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77035 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51163 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
11001022 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9427 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9379 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
36 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
230 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
99245 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
99816 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-141425 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
62971 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
177 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5157 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11720 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35700 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-31424 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-44988 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8188 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5563 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
77035 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
51163 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
290948 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41382 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3749 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
209 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3749 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-209 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
14155 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14155 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
273044 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-41591 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2565992 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2839036 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1994841 usd
CY2024Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
138000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 us-gaap Dividends
Dividends
57858 usd
CY2023Q1 us-gaap Dividends
Dividends
0 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46890 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
41198 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32850 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32814 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q1 pfho Number Of Customers
NumberOfCustomers
3 pure
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
48552 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
42660 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
10665 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
9903 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0575 pure
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0575 pure
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46890 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34920 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44519 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
46890 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
56489 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
36414 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12138 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
48552 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1662 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
46890 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
10665 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
9903 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-06-05
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2024Q1 us-gaap Dividends Cash
DividendsCash
1281600 usd
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
16000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
197403 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77035 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.281 pure
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51163 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-24-000485-index-headers.html Edgar Link pending
0001185185-24-000485-index.html Edgar Link pending
0001185185-24-000485.txt Edgar Link pending
0001185185-24-000485-xbrl.zip Edgar Link pending
ex_671466.htm Edgar Link pending
ex_671467.htm Edgar Link pending
ex_671468.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20240331_10q.htm Edgar Link pending
pfho-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
pfho-20240331_cal.xml Edgar Link unprocessable
pfho-20240331_def.xml Edgar Link unprocessable
pacifichco20240331_10q_htm.xml Edgar Link completed
pfho-20240331_lab.xml Edgar Link unprocessable
pfho-20240331_pre.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable